About Rabeprazole 20 mg & Itopride 150 mg (Sustained Release)
Rabeprazole 20 mg & Itopride 150 mg (Sustained Release) is a potent combination medicine designed to treat moderate to severe or unresponsive GERD (Gastroesophageal Reflux Disease) and reflux esophagitis. Available in capsule and tablet form, this dual-action formula targets gastric issues effectively. Rabeprazole 20 mg works as a proton pump inhibitor, reducing gastric acid production, while Itopride 150 mg improves gastrointestinal motility for enhanced digestive performance. Suitable for daily consumption, the recommended dosage is one capsule or tablet per day. Specifically formulated for individuals with persistent or chronic gastric conditions, this general medicine combination is highly effective for managing reflux and digestive discomfort. Ideal for export, manufacturing, and supply purposes, it is tailored for therapeutic use in clinical or commercial environments.
FAQs of Rabeprazole 20 mg & Itopride 150 mg (Sustained Release):
Q: What is the primary function of Rabeprazole 20 mg & Itopride 150 mg (Sustained Release)?
A: It is designed to treat moderate to severe or unresponsive GERD and reflux esophagitis.
Q: How does this medicine work?
A: Rabeprazole reduces gastric acid production, while Itopride enhances gastrointestinal motility.
Q: What is the recommended dosage for this product?
A: The recommended dosage is one capsule or tablet daily.
Q: Who is this medicine recommended for?
A: It is recommended for individuals suffering from persistent gastric issues like GERD and reflux esophagitis.
Q: What forms is this medicine available in?
A: It is available in capsule and tablet form.